Certara Announces Appointment of President of its Software Division

PRINCETON, N.J.—September 17, 2020.  Certara, the global leader in biosimulation, today announced the appointment of Leif E. Pedersen as president of its software division, reporting to Chief Executive Officer William F. Feehery, PhD. Mr. Pedersen is a seasoned software industry executive with more than 25 years of experience across a range of software categories. He … Continued

Certara Announces Changes to its Board of Directors

PRINCETON, N.J.—September 1, 2020.  Certara, the global leader in biosimulation, today announced changes to its board of directors, which took effect August 26, 2020.  After successfully transitioning the leadership of Certara to Chief Executive Officer William Feehery, Edmundo Muniz has decided to step down from the board.  William Klitgaard, who has served on the board … Continued

Certara Announces First Enrollee in International Registry to Assess Preventative Therapies in Healthcare Workers Exposed to COVID-19

Real-World Data on 10,000 Healthcare Workers to Inform COVID-19 Prevention Policies PRINCETON, N.J.—August 13, 2020. Certara®, the global leader in biosimulation, has launched an international registry of healthcare workers to collect information on risk factors for developing COVID-19 and the use of preventative therapies.  The International Registry of Healthcare Workers Exposed to COVID-19 (UNITY Global) … Continued

Certara Announces New COVID-19 Biosimulation Platform and Key Updates to Its Quantitative Systems Pharmacology (QSP) Technology Platforms

Major platform advancements demonstrate applicability of biosimulation to accelerate drug discovery and development PRINCETON, NJ – Aug 10, 2020 – Certara®, the global leader in biosimulation, today announced the development of a new biosimulation platform for COVID-19 vaccines and major enhancements in its Immunogenicity and Immuno-oncology QSP platforms.  Certara has partnered with leading, global pharmaceutical … Continued

Certara Announces Launch of Pediatrics Practice with Scientific and Regulatory Experts

Combination of experts and software helps accelerate pediatric drug development and increase clinical trial success rates PRINCETON, NJ – July 29, 2020 – Today, Certara®, the global leader in biosimulation, launches Certara Pediatrics, a new practice area to help biopharmaceutical companies apply model-informed drug development to their pediatric programs and better navigate the changing regulatory landscape. … Continued

Certara Launches Version 8.3 of Phoenix™ Biosimulation Software for Drug Development

Latest updates demonstrate commitment to customers and market leadership of Phoenix Platform PRINCETON, N.J.—June 24, 2020. Certara®, the global leader in biosimulation, today announced the launch of version 8.3 of its Phoenix™ platform, the industry gold standard in pharmacokinetic/ pharmacodynamic (PK/PD) and toxicokinetic modeling and simulation software. Version 8.3 delivers new features to drive efficiencies and … Continued

Back to top